All studies
RecruitingNAINTERVENTIONAL

Substrate Remodelling and Targeted Ablation in AF

Atrial fibrillation (AF) is a common condition causing an irregular heartbeat. While a procedure called catheter ablation can treat it, it doesn't work for everyone. This study at St Bartholomew's Hospital aims to improve this treatment. Researchers will create detailed 3D maps of the heart's upper left chamber to understand why AF continues in some people and how to make ablation more successful. All participants will receive this special mapping during their ablation. If AF returns, some may have a second, targeted ablation. Patients will be followed for a year to see if this new approach reduces further procedures and improves their health and well-being.

At a glance

Status
Recruiting
Phase
NA
Sponsor
Barts & The London NHS Trust
Enrolment target
160
Start
07 Nov 2025
Estimated completion
18 Aug 2030

What is this study about?

Atrial fibrillation (AF) is a very common heart condition where your heart beats irregularly. Millions of people in the UK experience symptoms like palpitations (a fluttering heart), feeling tired, and breathlessness. It can also increase your risk of stroke and heart failure, so finding effective treatments is really important.

One common treatment is called catheter ablation. This procedure involves doctors guiding thin wires into your heart, usually from a blood vessel in your leg. They then use controlled energy to carefully target and correct the areas causing your heart to beat irregularly. However, this procedure doesn't always work perfectly, and about half of patients find their AF returns, meaning they might need further treatment or continue to live with the condition.

This study, taking place at St Bartholomew's Hospital, wants to make catheter ablation more effective. Researchers will use advanced mapping techniques to create a very detailed 3D picture of your heart's upper left chamber. This picture will show them exactly how electrical signals travel through your heart, highlighting any abnormal areas or scarring. They'll also look at nerve activity. By understanding these tiny details, they hope to figure out why AF keeps coming back in some people and how to improve ablation procedures. All participants will have this special mapping done during their ablation. If AF returns, some patients might be offered a second, specially targeted ablation based on what the maps showed. The researchers will then follow patients for 12 months to see if this detailed mapping leads to better, longer-lasting results, reduces the need for more procedures, and ultimately improves patients' quality of life.

Key takeaways

  • Targets AF, a common irregular heartbeat condition.
  • Aims to improve catheter ablation success rates.
  • Uses advanced 3D heart mapping during the procedure.
  • Includes follow-up for 12 months to assess results.
  • May lead to more effective, personalised treatment for AF.
  • Taking place at St Bartholomew's Hospital.

Who may be eligible?

To be considered for this study, you need to be an adult aged 18 or older and have a type of atrial fibrillation called persistent AF. You must also be scheduled to have your first-ever catheter ablation procedure for persistent AF. It's important that you are able and willing to understand and sign the consent forms to take part.

There are also some reasons why you wouldn't be able to join. These include being under 18 years old or having already had a catheter ablation in the past for AF or other heart rhythm problems in the upper chambers of your heart. Also, if your doctor believes that having the standard AF catheter ablation procedure would not be suitable for you due to other health reasons, you wouldn't be able to participate in this study.

Quick self-check
  • Are you 18 years old or over?
  • Do you have 'persistent atrial fibrillation'?
  • Are you scheduled for your very first catheter ablation for this condition?
  • Are you able to understand and sign consent forms?
  • Have you *never* had an ablation for AF before?

This is a guide only — the research team will confirm whether you can take part.

What does participation involve?

If you decide to take part, you will have a catheter ablation procedure that includes special detailed heart mapping. If your AF returns after this first procedure, you might be invited for a second ablation, which will be specifically guided by the detailed maps made of your heart. After your procedure(s), you will have regular check-ups with the study team for 12 months. These check-ups will be at 3, 6, 9, and 12 months. At the 6-month and 12-month visits, you will also wear a small heart monitor (an ECG recorder) for 48 hours to check your heart rhythm. The total duration of your active participation, including follow-up, will be 12 months.

Potential risks and benefits

Participating in this study might offer you the potential benefit of having a more advanced and potentially more effective catheter ablation, which could reduce the chance of your AF returning, though this is not guaranteed. However, as with any medical procedure, there are potential risks associated with catheter ablation itself, which your doctor will discuss with you. These risks are not increased by the study's mapping techniques. You are free to withdraw from the study at any time, for any reason, without it affecting your medical care.

Locations (1)

  • St Bartholomew's Hospital
    London, United Kingdom· Recruiting

Common questions

What is atrial fibrillation (AF)?

AF is a common condition where your heart beats irregularly, which can make you feel tired, dizzy, or breathless.

What is catheter ablation?

It's a procedure where doctors use thin wires to correct problem areas in your heart that cause the irregular heartbeat.

What is 'heart mapping' in this study?

It's a special way of creating a very detailed 3D picture of your heart to help doctors find and treat the exact areas causing AF.

Will I have a second procedure if the first doesn't work?

If your AF returns, you might be invited for a second, targeted ablation based on the detailed maps made of your heart during the first procedure.

How long will I be involved in the study?

You'll be followed up for 12 months after your procedure, with regular check-ups and heart rhythm monitoring.

How to find out more

Shohreh Honarbakhsh, MBBS, MRCP, PhD

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "Substrate Remodelling and Targeted Ablation in AF…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.